TP53 and B-cell chronic lymphocytic leukemia: HIF-1α is overexpressed in CLL cells in TP53-disrupted patients, and the HIF-1α inhibitor BAY87-2243 exerts cytotoxic effects on CLL cells and has shown antitumor activity in Eμ-TCL1 mice [14].